Fundamental Analysis
24 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -8.1% | -59.2% | 0 / 3 | -21.3% | +1.53 pp | +1.05 pp | +5.4% | 1.01 | 24.04 | 402 | −21,3% | 26,4 | −6,4% | 24.04 | 13.14 | +83,0% |
| Pts | 0 | 0 | 0 | 0 | 8 | 8 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 19.000 (close price on 2026-09-24)EPS (TTM): 790,4
Financial charts
1.Revenue & growth
VND bn402Q2/26
1.Revenue & growth
VND bn402Q2/26
2.Profit & growth
VND bn26,1Q2/26
3.Profit mix (Penman)
VND bn31,5Q2/26
4.Margins & cost structure
%6.8%Q2/26
5.Returns & cash cycle
% · days-2.0%Q2/26
6.Earnings quality & cash
VND bn-516Q2/26
7.Asset structure
VND bn1.667Q2/26
8.Funding & debt health
VND bn · times1.667Q2/26
9.Revenue backlog
VND bn77,3Q2/26
10.Valuation
times · %23,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %676Q2/26
Adjusted EPS growth, latest quarter
-8.1%
Average adjusted EPS growth, 3 quarters
-58.4%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26